Product Description
These medicines are effective in the treatment of kaposis sarcoma. With healthy experience of several years and complete knowledge of the industry, we are engaged in offering Daunomycin Medicines. Doctors use is with other cancer medications to subside the progression of cancers of the white blood cell.Highly demanded in the market, these medicines come in different strengths of dosage. We offer Daunomycin Medicines at market leading prices to clients.
Features:
- Accurate composition
- Low chances of side effects
- Effective antineoplastic agent
INDICATORS
- Pregnancy:D Lactation:L4 Lab:NA Food:NATYPICAL USAGE
- Acute leukemia, HIV related kaposis sarcoma.
Targeted Therapy for Acute LeukemiaDaunomycin is specifically indicated for the treatment of acute lymphocytic and myeloid leukemia. Acting as an antineoplastic agent, it plays a vital role in induction therapy during oncology protocols, directly targeting malignant cells by interfering with DNA synthesis and enzymatic activity.
Premium Purity and Stable FormulationThis product boasts a purity of greater than 99%, ensuring reliable performance and consistent therapeutic results. Daunomycin is provided in ready-to-use sterile vials, and its stability allows for refrigerated storage between 2C and 8C, safeguarding its potency throughout its 24-month shelf life.
Safe Handling and Administration GuidelinesAs a cytotoxic drug, Daunomycin requires careful handling using gloves and protective clothing to minimize occupational exposure. The red crystalline powder must be reconstituted with sterile water prior to intravenous administration, ensuring accurate dosing and patient safety within healthcare settings.
FAQs of Daunomycin Medicines:
Q: How should Daunomycin be stored to maintain its effectiveness?
A: Daunomycin vials should be kept refrigerated between 2C and 8C and protected from light, preserving their stability and extending the shelf life up to 24 months.
Q: What is the recommended process for reconstituting Daunomycin prior to use?
A: To prepare Daunomycin for intravenous administration, dissolve the red crystalline powder in sterile water for injection according to clinical guidelines, ensuring the solution is clear before use.
Q: When is Daunomycin typically prescribed in clinical oncology?
A: Daunomycin is commonly used during induction therapy for patients diagnosed with acute lymphocytic or myeloid leukemia, helping to reduce malignant cell populations during initial cancer treatment stages.
Q: Where is Daunomycin administered and by which route?
A: Daunomycin is administered in clinical or hospital settings via intravenous injection to ensure precise dosing and professional monitoring of patient response.
Q: What handling precautions must be followed with Daunomycin?
A: Because Daunomycin is cytotoxic, healthcare professionals should always wear gloves and protective clothing when handling the drug to avoid any accidental exposure.
Q: How does Daunomycin benefit patients with acute leukemia?
A: By intercalating DNA and inhibiting topoisomerase II, Daunomycin disrupts cancer cell replication, offering a targeted approach to reduce leukemia cell numbers and improve patient outcomes during chemotherapy.